valoctocogene roxaparvovec
BMN 270-201
Phase 2 mab completed
Quick answer
valoctocogene roxaparvovec for Severe Haemophilia A is a Phase 2 program (mab) at BioMarin International Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BioMarin International Limited
- Indication
- Severe Haemophilia A
- Phase
- Phase 2
- Modality
- mab
- Status
- completed